A feud between Prime Medicine and Tessera Therapeutics, two gene-editing companies, has spilled out into public.

Wall Street analysts have also been skeptical of whether its lead program is worth the investment. While positive clinical results could prove prime editing’s worth, the disease affects an estimated ...

If you’re a dedicated Apple user, look no further than the MacBook Pro (2023). With the latest M3 chip processor, this laptop ...

Our editor's cart is full of Prime Day beauty deals, with discounts on a cult-favorite lip balm, a Dyson Airwrap dupe, and ...

Prime Medicine, a biotech company that set out to use its more precise approach to gene editing to develop new one-time treatments for rare diseases, is expanding its scope to more prevalent ...

Prime Day clothing deals are ending soon, but we've found plenty of cute styles for fall. Here's what we scouted from ...

Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company specializing in gene editing therapies, has garnered significant attention from analysts and investors alike for its innovative prime ...

This funding, provided through the NIH’s Somatic Cell Genome Editing Program, will support gene-editing research aimed at ...

To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. Prime Medicine will streamline research in a bid to focus on what its executives believe to be its most ...

My Prime Day strategy this year is simple ... has over 54,000 five-star reviews on Amazon and has impressed most every beauty editor I know. After using it the first time (here's my full review ...

Prime has granted to BMS an exclusive worldwide license to its Prime Editing technology, through which Prime agreed to design Prime Editing reagents through its Prime Assisted Site-Specific ...